Terminated Contracts

The following are descriptions of global health contracts that were deemed life-saving and granted waivers but were abruptly terminated by the administration across two days, prior to a key court deadline. This is a constantly evolving list.

  • The termination of JHPIEGO’s Momentum Country and Global Leadership program will impact 4.5 million women and children. The program delivers critical maternal and newborn health care, including work to prevent postpartum hemorrhage and support for small and sick newborns. This termination will directly increase maternal and child mortality.

    JHPIEGO, based in Maryland, operates this maternal and child health and malaria program in Madagascar, Nepal, Kenya, Cote D'Ivoire, and Sierra Leone.

  • The termination of Chemonics’ Global Health Supply Chain Procurement and Supply Management (GHSC-PSM) TO2 Malaria program will disrupt lifesaving interventions for 40.3 million people over the next 30 days. The program delivers life-saving malaria prevention, treatment, and diagnostics in a country facing ongoing crises.

    Chemonics, based in Washington DC, operates this malaria program across Angola, Benin, Burma, Burkina Faso, Burundi, Cambodia, Cameroon, Cote d'Ivoire, DRC, Ethiopia, the Gambia, Ghana, Guinea, Liberia, Kenya, Madagascar, Malawi, Mali, Mozambique, Niger, Nigeria, Rwanda, RDMA, Uganda, Senegal, Sierra Leone, Tanzania, Togo, Zambia, and Zimbabwe.

  • The termination of PATH’s PMI REACH program will impact 2.1 million children during the upcoming peak malaria season. The program delivers critical malaria prevention and treatments. This termination will directly increase child mortality.

    PATH, based in Washington state, operates a malaria program in Togo and Mali.

  • The termination of Management Science for Health’s USAID Supply Chain Strengthening program will destroy the supply chain of critical health care products for malaria, TB, and maternal and child health services across conflict-affected areas of Ethiopia. Suspending this work would disrupt the supply of life-saving medicines and health supplies for malaria, TB, and maternal and child health across Ethiopia, including in conflict-affected areas, leaving thousands without essential care.

    Management Science for Health, based in Virginia, operates this program addressing maternal and child health, tuberculosis, and malaria in Ethiopia.

  • The termination of ADPP’s Transform Nutrition program will immediately impact almost 30,000 children in Mozambique who won’t receive life-saving treatment and care. The program delivers critical care for malnutrition, deworming, and vitamins. Eliminating these low-cost preventative treatments will lead to increased mortality among pregnant and lactating women and malnourished children.

    ADPP, based in Mozambique, operates a nutrition program within the country.

  • The termination of EngenderHealth’s Lowlands Health Activity program will interrupt the life-saving health services for 244,500 mothers and children in a 30-day period. The program provides life-saving postpartum care and ensures the availability of lifesaving products such as medicine, vaccines, and vitamins. The program provides newborns with life-saving resuscitation and mothers with care to prevent postpartum hemorrhage, this termination will directly increase maternal and child mortality.

    EngenderHealth, based in Washington DC, operates this maternal and child health program in Ethiopia.

  • The termination of FHI 360’s Feed the Future Ethiopia Community Nutrition Activity program ended low-cost life-saving care for severely malnourished children and severely malnourished pregnant and lactating women. Over two million children in Ethiopia suffer from malnutrition, and the death rate among these children is 10.3%. Without these services, over 5,000 children may die in just 30 days.

    FHI 360, based in North Carolina, operates this maternal and child health and nutrition program in Ethiopia.

  • The termination of Management Science for Health’s USAID Supply Chain Strengthening program will destroy the supply chain of critical health care products for malaria, TB, and maternal and child health services across conflict-affected areas of Ethiopia. Suspending this work would disrupt the supply of life-saving medicines and health supplies for malaria, TB, and maternal and child health across Ethiopia, including in conflict-affected areas, leaving thousands without essential care.

    Management Science for Health, based in Virginia, operates this program addressing maternal and child health, tuberculosis, and malaria in Ethiopia.

  • The termination of Global Environment & Technology Foundation’s Project Last Mile program could lead to increased severity of disease and death among the 200,000 people who rely on these services across over 100 sites. The program delivers technical support, internet connectivity (which allows requests for essential medicines), and a private-sector distribution model to ensure the timely replenishment of essential medicines and supplies while aligning leadership for long-term sustainability. This disruption will affect the delivery of life-saving medications and supplies such as insulin, oxygen, oral rehydration salts, IV bags, ventilators, and scalpel blades.

    Global Environment & Technology Foundation, based in Virginia, operates this supply chain program in Sierra Leone.

  • The termination of the JSI Digital Health Activity program could lead to disruptions in the procurement and distribution of critical medicines, threatening uninterrupted treatment for TB and malaria patients and continued maternal and newborn care. The program delivers essential health supply chain management services, including the distribution of diagnostic tools and outbreak containment resources for emergency responses. This termination threatens to severely impact Ethiopia’s healthcare system by reducing access to life-saving treatments and weakening the country's ability to respond to infectious disease outbreaks.

    JSI, based in Massachusetts, operates this health supply chain management program in Ethiopia.

  • The termination of PSI’s MOMENTUM Private Healthcare Delivery project could put 500,000 lives at risk over the next 90 days. The program delivers essential healthcare services, including the distribution of medicines and health supplies, supply chain management, disease surveillance, clinical monitoring, and health worker training to ensure lifesaving care. This termination threatens to disrupt critical healthcare functions in Burundi, including safe pregnancy and delivery, newborn care, immunization, treatment of acute childhood illness, and communications to inform communities about mpox risks and the use of essential medicines.

    PSI, based in Washington DC, operates this supply chain management and healthcare delivery program in Burundi.

  • The termination of the Abt Global PMI Evolve Project will lead to 4.65 million people at an increased risk of malaria transmission. The program delivers critical malaria prevention services, including indoor residual spraying campaigns. This termination threatens to leave families in the highest burden areas of Kenya and Uganda at greater risk of malaria.

    Abt Global, based in Maryland, operates this malaria prevention program in Kenya and Uganda. 

  • The termination of RTI International’s Owod-Integrated District Health Project could lead to a severe decline in essential healthcare services, leaving many communities without access to life-saving interventions. The program provides malnutrition screening, immediate treatment for identified cases, deworming programs, and the distribution of vitamin A, and iron supplements—support that is often the difference between life and death. It also offers malaria prevention and treatment services. Abruptly ending these life-saving services will lead to increased mortality, particularly among vulnerable children and pregnant or lactating mothers.

    RTI International, based in North Carolina, operates this maternal, newborn, and child health program in Senegal.

  • The termination of Food and Agriculture Organization of the United Nations’ Global Health Security Project could lead to increased vulnerability to a potential bird flu (H5N1) pandemic that puts over 153 million people at direct risk, with possible case fatality rates up to 50% for some strains, resulting in tens of thousands of deaths, particularly among vulnerable populations in regions with limited healthcare resources. The program delivers critical outbreak response activities such as surveillance, early detection, diagnostic testing, sample transport, biosecurity, infection prevention, case management, public awareness, and accessing critical supplies. This termination poses a severe risk to human health, not just globally but here in America.

    Food and Agriculture Organization of the United Nations, based in Italy, operates this outbreak response worldwide.

  • The termination of Management Science for Health’s Health Resilience Activity program could lead to 4.7 million people being at risk of dying from the deadly diseases of malaria, cholera, measles, Ebola, and Marburg, including 750,000 children under the age of five. The program delivers life-saving services like infection control, case management, and treatment of outbreaks, with rapid response teams and expanded mobile services in conflict zones. This termination threatens to worsen the spread of these diseases not just in Ethiopia but worldwide, overwhelming healthcare systems and endangering vulnerable populations.

    Management Science for Health, based in Virginia, operates this outbreak response program in Ethiopia.

  • The termination of FHI 360’s STRIDE program could lead to the death of over 2,000 people in the next 30 days. The program delivers a coordinated mpox outbreak response, including critical mpox prevention and treatments. This termination threatens to worsen the spread of mpox not just in DRC, but worldwide, overwhelming healthcare systems and endangering vulnerable populations.

    FHI 360, based in North Carolina, operates this mpox outbreak prevention program in DRC.

  • The termination of the Centro de Colaboração em Saúde’s (CCS) Fostering Opportunities to Respond to the Tuberculosis Epidemic (FORTE) program will disrupt treatment for around 61,000 TB patients, potentially leading to 305,000 new infections, an increase in multidrug-resistant and extensively drug-resistant tuberculosis, and up to 13,000 deaths. This disruption threatens to worsen the spread of TB not only in Mozambique but worldwide, overwhelming healthcare systems and endangering vulnerable populations.

    CCS, based in Mozambique, operates this TB prevention and treatment program in Mozambique.

  • Global Alliance for TB Drug Detection TB Alliance project could have saved 10,000 lives over 90 days, but it was terminated abruptly. The project was developing drugs that shorten treatment for TB and provide options for patients with drug-resistant TB. This program manages the largest pipeline of new TB drugs in history.

    Global Alliance for TB Drug Detection, based in New York, operates this TB program in Georgia, the Philippines, South Africa, Tanzania, and Uganda.

  • EngenderHealth’s Momentum Safe Surgery in Family Planning and Obstetrics (MSSFPO) program could have provided 4,496 women with safe surgeries in the next 30 days, but it was abruptly terminated. They provide essential medical equipment and operation funds for surgical teams to conduct cesarean sections to ensure maternal and newborn healthy outcomes.

    EngenderHealth, based in Washington, DC, operates MSSFPO in Benin, Burundi, DRC, India, Madagascar, Mali, Mozambique, and Senegal.

  • The termination of FHI360’s Achieving Quality Health Services for Women and Children program puts almost 5,000 women at risk of death from birth complications within the next 90 days. Abruptly ending community-based treatment puts 20,000 children at risk of death due to pneumonia and diarrhea. Additionally, 272,865 children will not be reached with essential vaccines, increasing the risk of outbreaks of measles and polio.

    FHI360, based in North Carolina, operates Achieving Quality Health Services for Women and Children in Mozambique.